These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Parathyroid carcinoma: biochemical and pathologic response to DTIC. Calandra DB; Chejfec G; Foy BK; Lawrence AM; Paloyan E Surgery; 1984 Dec; 96(6):1132-7. PubMed ID: 6505966 [TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial. Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma. Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156 [TBL] [Abstract][Full Text] [Related]
5. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens. Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489 [TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with upper gastrointestinal carcinomas. Ajani JA Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271 [TBL] [Abstract][Full Text] [Related]
7. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study. Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628 [TBL] [Abstract][Full Text] [Related]
8. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]. Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237 [TBL] [Abstract][Full Text] [Related]
9. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K; Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of metastatic adrenal carcinoma with suramin]. Allolio B; Jaursch-Hancke C; Reincke M; Arlt W; Metzler U; Winkelmann W Dtsch Med Wochenschr; 1989 Mar; 114(10):381-4. PubMed ID: 2924693 [TBL] [Abstract][Full Text] [Related]
11. [A combination chemotherapy with CDDP and 5-FU effective for pulmonary metastases in a case of parotid gland carcinoma]. Furuse S; Mizushima Y; Mino T; Yoshida Y; Nakagawa H; Asou S; Wakagi K; Kobayashi M Gan To Kagaku Ryoho; 1996 Jul; 23(8):1059-62. PubMed ID: 8687222 [TBL] [Abstract][Full Text] [Related]
12. The activity of paclitaxel in gastrointestinal tumors. Ajani JA; Ilson DH; Kelsen DP Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
14. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy]. Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739 [TBL] [Abstract][Full Text] [Related]
15. [Irinotecan in combination with 5-fluorouracil and leucovorin in the treatment of metastatic colorectal cancer]. Prausová J; Kubácková K; Linke Z; Kubala E; Pipková R; Hladíková J Cas Lek Cesk; 2005; 144(11):747-51; discussion 752. PubMed ID: 16335701 [TBL] [Abstract][Full Text] [Related]
16. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061 [TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion. Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346 [TBL] [Abstract][Full Text] [Related]
18. Metastatic parathyroid carcinoma (mPCa): natural history and treatment of a case. Vainas IG; Tsilikas C; Grecu A; Pasaitu K; Stergiou I; Kortsaris AH J Exp Clin Cancer Res; 1997 Dec; 16(4):429-32. PubMed ID: 9505219 [TBL] [Abstract][Full Text] [Related]
19. One-hour paclitaxel in the treatment of non-small cell lung cancer. Hainsworth JD; Greco FA Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133 [TBL] [Abstract][Full Text] [Related]
20. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma]. Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]